NEUROENDOCRINE TUMOR
Clinical trials for NEUROENDOCRINE TUMOR explained in plain language.
Never miss a new study
Get alerted when new NEUROENDOCRINE TUMOR trials appear
Sign up with your email to follow new studies for NEUROENDOCRINE TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for slowing advanced neuroendocrine tumors in Final-Stage trial
Disease control OngoingThis study is testing whether the drug cabozantinib can slow the growth of advanced neuroendocrine tumors better than a placebo in people whose cancer has continued to worsen despite prior treatments. About 298 participants with specific advanced neuroendocrine tumors will be ran…
Matched conditions: NEUROENDOCRINE TUMOR
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
Major cancer trial tests new hope for patients Who've run out of options
Disease control OngoingThis study tested pembrolizumab, an immunotherapy drug, in people with advanced solid tumors who had already tried standard treatments that stopped working. Researchers enrolled 1,609 participants with various cancers including anal, cervical, lung, and thyroid cancers to see how…
Matched conditions: NEUROENDOCRINE TUMOR
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Apr 02, 2026 14:58 UTC
-
Major cancer trial tests new drug duos for rare, aggressive tumors
Disease control OngoingThis large Phase 3 trial aims to find the better treatment combination for patients with advanced, high-risk neuroendocrine tumors (like carcinoid tumors) that have spread. Researchers are comparing a standard drug (octreotide) paired with either interferon or bevacizumab to see …
Matched conditions: NEUROENDOCRINE TUMOR
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
Scientists launch major registry to track elusive neuroendocrine tumors
Knowledge-focused ENROLLING_BY_INVITATIONThis study is creating a registry to collect information and blood samples from people with neuroendocrine tumors (NETs). The main goal is to learn more about these cancers and to see how well a specific blood test, called NETest, works for diagnosis and tracking the disease over…
Matched conditions: NEUROENDOCRINE TUMOR
Sponsor: Wren Laboratories LLC • Aim: Knowledge-focused
Last updated Apr 02, 2026 14:57 UTC